How Health Insurers Use Your DNA Test Results

Direct-to-consumer genetic testing promised health insights, but what happens to your data when you spit in that tube? In this episode, Lucas and Luna explore how health insurers are increasingly using genetic data to inform underwriting and premium decisions. They break down the case of a woman denied coverage after a 23andMe test revealed a genetic marker for a rare condition, and examine the legal loopholes that allow insurers to access this sensitive information. They discuss the Genetic Information Nondiscrimination Act (GINA) and why it does not fully protect consumers, the role of big data brokers who sell genetic profiles, and the ethical implications of using DNA to predict future health costs. With concrete examples and a look at the murky world of data sharing, they ask: how much do you really know about what happens to your DNA? Tune in for a revealing conversation on the intersection of genetics, data, and insurance. #GeneticData #HealthInsurance #DNATesting #Privacy #InsuranceUnderwriting #GINA #DataBrokers #ConsumerRights #Genetics #Healthcare #InsuranceTech #Biotech #PersonalData #Economics #FexingoBusiness #BusinessPodcast #DataPrivacy #InsuranceIndustry Keep every episode free: buymeacoffee.com/fexingo